Buscar | NEXTO

Anuj Mrfr agregó una foto Health
2026-01-15 11:17:20 -

Ustekinumab Market: Is "Dermatology" Still the Revenue King in 2026?
Despite the growth in gastroenterology, "Psoriasis" remains the largest revenue-generating indication for the ustekinumab market in 2026. In 2026, the market for moderate-to-severe plaque psoriasis is identifying as a "saturated but stable" segment, with millions of long-term users maintaining their skin clearance through ustekinumab. This 2026 trend is driven by the drug’s proven safety...

0 Commentarios 0 Acciones 18 Views 0 Vista previa

Please log in to like, share and comment!
Ksh Dbmr agregó una foto Networking
2025-12-10 09:26:32 -

What’s Accelerating Adoption in the Global Ustekinumab Market for Autoimmune Care?
Executive Summary Ustekinumab Market Size and Share: Global Industry Snapshot CAGR Value The global ustekinumab market size was valued at USD 12.07 billion in 2024 and is expected to reach USD 19.09 billion by 2032, at a CAGR of 5.90% during the forecast period Businesses can depend with confidence upon this superior Ustekinumab Market report to bring about an utter success. An...

0 Commentarios 0 Acciones 109 Views 0 Vista previa

Please log in to like, share and comment!